– First-quarter revenues grew organically by 21.0% – Adjusted EBITDA up organically by 24.8% – Gerresheimer confirms guidance for financial year 2023 DÜSSELDORF, Germany, April 6, 2023 /PRNewswire/ — Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.